DK0589004T4 - Fremgangsmåde til bestemmelse af peptider, som hörer til immunologisk vigtige epitoper af HCV - Google Patents
Fremgangsmåde til bestemmelse af peptider, som hörer til immunologisk vigtige epitoper af HCVInfo
- Publication number
- DK0589004T4 DK0589004T4 DK93906490T DK93906490T DK0589004T4 DK 0589004 T4 DK0589004 T4 DK 0589004T4 DK 93906490 T DK93906490 T DK 93906490T DK 93906490 T DK93906490 T DK 93906490T DK 0589004 T4 DK0589004 T4 DK 0589004T4
- Authority
- DK
- Denmark
- Prior art keywords
- hcv
- immunologically important
- important epitopes
- peptides belonging
- determining peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
- C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92400598 | 1992-03-06 | ||
PCT/EP1993/000517 WO1993018054A2 (en) | 1992-03-06 | 1993-03-08 | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0589004T3 DK0589004T3 (da) | 1999-11-15 |
DK0589004T4 true DK0589004T4 (da) | 2004-08-16 |
Family
ID=8211622
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93906490T DK0589004T4 (da) | 1992-03-06 | 1993-03-08 | Fremgangsmåde til bestemmelse af peptider, som hörer til immunologisk vigtige epitoper af HCV |
DK98202777T DK0891982T3 (da) | 1992-03-06 | 1993-03-08 | HIV-peptider |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98202777T DK0891982T3 (da) | 1992-03-06 | 1993-03-08 | HIV-peptider |
Country Status (16)
Country | Link |
---|---|
US (3) | US6165730A (ko) |
EP (2) | EP0891982B1 (ko) |
JP (2) | JP3443809B2 (ko) |
KR (3) | KR20030096423A (ko) |
AT (2) | ATE179716T1 (ko) |
AU (1) | AU671623B2 (ko) |
BR (1) | BR9305435A (ko) |
CA (1) | CA2102301C (ko) |
DE (2) | DE69324751T3 (ko) |
DK (2) | DK0589004T4 (ko) |
ES (2) | ES2287969T3 (ko) |
GR (1) | GR3030595T3 (ko) |
NZ (2) | NZ299048A (ko) |
PT (1) | PT891982E (ko) |
SG (1) | SG77551A1 (ko) |
WO (1) | WO1993018054A2 (ko) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US7413537B2 (en) * | 1989-09-01 | 2008-08-19 | Dyax Corp. | Directed evolution of disulfide-bonded micro-proteins |
AU8740491A (en) * | 1990-09-28 | 1992-04-28 | Protein Engineering Corporation | Proteinaceous anti-dental plaque agents |
EP0644202B1 (en) * | 1990-12-14 | 1997-03-05 | N.V. Innogenetics S.A. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
ES2287206T3 (es) * | 1991-03-01 | 2007-12-16 | Dyax Corporation | Proceso para el desarrollo de mini-proteinas de union. |
US5773211A (en) * | 1991-07-10 | 1998-06-30 | Abbott Laboratories | Differentiation of HTLV-I and HTLV-II using synthetic peptides |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
US6667387B1 (en) * | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
JP2723360B2 (ja) * | 1992-05-29 | 1998-03-09 | ハワード・フローレイ・インスティテュート・オブ・エクスペリメンタル・フィジオロジー・アンド・メディスン | オリゴヌクレオチド−ポリアミドコンジュゲート |
IT1270941B (it) * | 1993-05-12 | 1997-05-26 | Sorin Biomedica Spa | Peptidi di hcv e loro usi. |
JPH08510240A (ja) | 1993-05-12 | 1996-10-29 | カイロン コーポレイション | C型肝炎ウイルスe2/ns1領域の保存モチーフ |
EP0729973A4 (en) * | 1993-10-29 | 1998-12-30 | Srl Inc | AN ANTIQUE PEPTIDE COMPOUND AND IMMUNOASSAY PROCEDURE |
ES2197170T3 (es) | 1993-11-04 | 2004-01-01 | Innogenetics N.V. | Epitopos de celulas t humanas inmunologicamente dominantes del virus de la hepatitis c. |
CA2179381A1 (en) * | 1993-12-20 | 1995-06-29 | Jessie W. Shih | Differentiation of htlv-i and htlv-ii using synthetic peptides |
US5709995A (en) | 1994-03-17 | 1998-01-20 | The Scripps Research Institute | Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
GB9410044D0 (en) * | 1994-05-19 | 1994-07-06 | Int Murex Tech Corp | Assay |
US6184205B1 (en) * | 1994-07-22 | 2001-02-06 | University Of North Carolina At Chapel Hill | GRB2 SH3 binding peptides and methods of isolating and using same |
US6303574B1 (en) | 1994-07-22 | 2001-10-16 | The University Of North Carolina At Chapel Hill | Scr SH3 binding peptides and methods of isolating and using same |
US5804371A (en) * | 1994-07-25 | 1998-09-08 | Boehringer Mannheim Gmbh | Hapten-labelled peptides |
CN1114106C (zh) * | 1994-07-25 | 2003-07-09 | 罗切诊断学有限公司 | 金属螯合物标记的肽及其制备方法 |
DE69526636T3 (de) | 1994-07-29 | 2006-11-23 | Innogenetics N.V. | Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung |
JP3665371B2 (ja) * | 1994-08-31 | 2005-06-29 | 株式会社先端生命科学研究所 | C型肝炎ウイルス感染又はグループ判定のためのエピトープキメラ抗原ペプチド、その製法、及びそれを使用する感染又はグループ判定法 |
AU780017B2 (en) * | 1994-10-20 | 2005-02-24 | Institut Pasteur | Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
FR2731225B1 (fr) * | 1995-03-03 | 2003-10-31 | Pasteur Institut | Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique |
JP4278174B2 (ja) * | 1994-10-20 | 2009-06-10 | アンスティテュ・パストゥール | Hiv−1のoグループ(またはサブグループ)レトロウイルス性抗原のヌクレオチド配列 |
DE19504302A1 (de) * | 1995-02-09 | 1996-08-14 | Boehringer Mannheim Gmbh | Methode zur serologischen Typisierung mittels typspezifischer Antigene |
DE19505262C2 (de) * | 1995-02-16 | 1998-06-18 | Behring Diagnostics Gmbh | Retrovirus aus der HIV-Gruppe und dessen Verwendung |
WO1996027012A1 (en) * | 1995-03-02 | 1996-09-06 | Akzo Nobel N.V. | Specific hiv-1 group o antigens |
US6309820B1 (en) | 1995-04-07 | 2001-10-30 | University Of North Carolina At Chapel Hill | Polypeptides having a functional domain of interest and methods of identifying and using same |
EP0833941B1 (en) | 1995-04-07 | 2008-10-22 | Cytogen Corporation | Polypeptides having a functional domain of interest and methods of identifying and using same |
EP0829488A4 (en) * | 1995-04-28 | 1999-04-07 | Srl Inc | ANTIGENIC PEPTIDE COMPOUND AND IMMUNOLOGICAL ASSAY METHOD |
US6110465A (en) * | 1995-06-07 | 2000-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
JPH0967395A (ja) * | 1995-08-31 | 1997-03-11 | S R L:Kk | 抗原ペプチド化合物および免疫学的測定方法 |
DE19534988A1 (de) * | 1995-09-21 | 1997-03-27 | Forssmann Wolf Georg | Verfahren zur Herstellung und Anwendung synthetischer, biotinylierter Peptide |
JP2002171972A (ja) * | 1996-10-14 | 2002-06-18 | Chemo Sero Therapeut Res Inst | 肝炎ウイルスエピトープ |
US6270777B1 (en) * | 1996-12-20 | 2001-08-07 | University Technologies International Inc. | Conserved metalloprotease epitopes |
FR2765688B1 (fr) * | 1997-07-04 | 1999-09-10 | Pasteur Institut | Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications |
DE69841919D1 (de) | 1997-11-06 | 2010-11-11 | Innogenetics Nv | Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke |
EP0947525A1 (en) * | 1998-03-27 | 1999-10-06 | Innogenetics N.V. | Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
EP1115847A1 (en) | 1998-09-25 | 2001-07-18 | Children's Medical Center Corporation | Short peptides which selectively modulate the activity of protein kinases |
SE9903031D0 (sv) * | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
IT1310160B1 (it) * | 1999-09-03 | 2002-02-11 | Invicta S P A | Zaino con schienale provvisto di lamina elastica |
JP2003064096A (ja) * | 2001-08-29 | 2003-03-05 | Mitsubishi Kagaku Bio-Clinical Laboratories Inc | C型肝炎ウイルス特異的細胞障害性t細胞認識エピトープ |
CA2462651A1 (en) * | 2001-10-05 | 2003-04-17 | Novozymes A/S | Kit for predicting binding of a specific antibody to a potential immunogen and method of screening |
CN100479859C (zh) * | 2002-03-20 | 2009-04-22 | 厦门大学 | 一种针对靶的空间变构现象筛选可抑制和/或激活所述靶生物活性的物质的方法 |
AU2004230606B2 (en) * | 2003-04-11 | 2009-03-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Multiple antigenic peptide assay for detection of HIV or SIV type retroviruses |
US7604804B2 (en) | 2004-02-09 | 2009-10-20 | University Of Maryland Biotechnology Institute | Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120 |
US20070073039A1 (en) * | 2005-09-29 | 2007-03-29 | Chisari Francis V | Peptides that inhibit viral infections |
US8865398B2 (en) | 2006-09-01 | 2014-10-21 | Abbott Laboratories | Combination hepatitis C virus antigen and antibody detection method |
WO2009044650A1 (ja) * | 2007-10-05 | 2009-04-09 | Kaneka Corporation | 免疫グロブリンおよび/または免疫グロブリン複合体に結合活性を有する、標識されたペプチド、および上記ペプチドを用いた免疫グロブリンの検出方法または測定方法 |
US8748130B2 (en) * | 2008-09-02 | 2014-06-10 | Antigen Express, Inc. | Human papillomavirus / Ii-Key hybrids and methods of use |
FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
AU2014234400B2 (en) | 2013-03-21 | 2017-11-16 | Sanofi-Aventis Deutschland Gmbh | Synthesis of hydantoin containing peptide products |
ES2624961T3 (es) | 2013-03-21 | 2017-07-18 | Sanofi-Aventis Deutschland Gmbh | Síntesis de productos de péptido que contienen imida cíclica |
US9850278B2 (en) | 2013-04-25 | 2017-12-26 | Carmel-Haifa University Economic Corp. | Synthetic anti-inflammatory peptides and use thereof |
JP6312225B2 (ja) * | 2013-12-27 | 2018-04-18 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | タンパク質に対するペプチドバインダーの系統的探索、成熟化、および伸長 |
WO2016169894A1 (en) | 2015-04-20 | 2016-10-27 | F. Hoffmann-La Roche Ag | Specific peptide binders to proteins identified via systemic discovery, maturation and extension process |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984003506A1 (en) * | 1983-03-08 | 1984-09-13 | Commw Serum Lab Commission | Antigenically active amino acid sequences |
US5075211A (en) * | 1986-03-26 | 1991-12-24 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
US4833071A (en) * | 1987-01-09 | 1989-05-23 | United Biomedical, Inc. | Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
EP0278940A3 (en) * | 1987-01-30 | 1988-12-07 | Smithkline Biologicals S.A. | Hepatitis b virus surface antigens and hybrid antigens containing them |
AU629528B2 (en) * | 1988-01-27 | 1992-10-08 | Biochem Pharma Inc. | Synthetic peptides and mixtures thereof for detecting hiv antibodies |
ES2072853T3 (es) * | 1988-06-09 | 1995-08-01 | Innogenetics Nv | Retrovirus hiv-3 y su utilizacion. |
DE3901857A1 (de) * | 1989-01-23 | 1990-07-26 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung von hiv 2 antikoerpern |
SU1612264A1 (ru) * | 1989-03-01 | 1990-12-07 | Институт биоорганической химии им.М.М.Шемякина | Способ твердофазного иммуноферментного определени антител к вирусу иммунодефицита человека и меченный биотином синтетический пептид дл его осуществлени |
HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
US5120662A (en) * | 1989-05-09 | 1992-06-09 | Abbott Laboratories | Multilayer solid phase immunoassay support and method of use |
DE69129207T2 (de) * | 1990-01-16 | 1998-10-08 | Orgenics Ltd | Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS |
KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
EP0445801A3 (en) * | 1990-03-08 | 1992-07-01 | Kuraray Co., Ltd. | Peptide and its use |
EP0448095A1 (en) * | 1990-03-21 | 1991-09-25 | Wolf, Hans Joachim, Prof. Dr. | Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections |
CA2047792C (en) * | 1990-07-26 | 2002-07-02 | Chang Y. Wang | Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
EP0770679B2 (de) * | 1990-11-03 | 2009-12-30 | Siemens Healthcare Diagnostics Products GmbH | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung |
EP0644202B1 (en) * | 1990-12-14 | 1997-03-05 | N.V. Innogenetics S.A. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
AU648912B2 (en) * | 1991-06-13 | 1994-05-05 | Dade International Inc. | Immunoassay for non-A non-B hepatitis |
ATE174382T1 (de) | 1992-10-06 | 1998-12-15 | Dade Behring Marburg Gmbh | Retrovirus aus der hiv-gruppe und dessen verwendung |
-
1993
- 1993-03-08 US US08/723,425 patent/US6165730A/en not_active Expired - Lifetime
- 1993-03-08 AT AT93906490T patent/ATE179716T1/de not_active IP Right Cessation
- 1993-03-08 NZ NZ299048A patent/NZ299048A/en not_active IP Right Cessation
- 1993-03-08 CA CA002102301A patent/CA2102301C/en not_active Expired - Lifetime
- 1993-03-08 WO PCT/EP1993/000517 patent/WO1993018054A2/en active IP Right Grant
- 1993-03-08 KR KR10-1999-7012596A patent/KR20030096423A/ko not_active Application Discontinuation
- 1993-03-08 AT AT98202777T patent/ATE364621T1/de active
- 1993-03-08 DE DE69324751T patent/DE69324751T3/de not_active Expired - Lifetime
- 1993-03-08 DK DK93906490T patent/DK0589004T4/da active
- 1993-03-08 AU AU37463/93A patent/AU671623B2/en not_active Expired
- 1993-03-08 DK DK98202777T patent/DK0891982T3/da active
- 1993-03-08 SG SG9605107A patent/SG77551A1/en unknown
- 1993-03-08 BR BR9305435A patent/BR9305435A/pt not_active IP Right Cessation
- 1993-03-08 PT PT98202777T patent/PT891982E/pt unknown
- 1993-03-08 DE DE69334148T patent/DE69334148T2/de not_active Expired - Lifetime
- 1993-03-08 NZ NZ249838A patent/NZ249838A/en active IP Right Revival
- 1993-03-08 KR KR1019930703359A patent/KR100257941B1/ko not_active IP Right Cessation
- 1993-03-08 JP JP51533493A patent/JP3443809B2/ja not_active Expired - Lifetime
- 1993-03-08 ES ES98202777T patent/ES2287969T3/es not_active Expired - Lifetime
- 1993-03-08 ES ES93906490T patent/ES2133392T5/es not_active Expired - Lifetime
- 1993-03-08 US US08/146,028 patent/US5891640A/en not_active Expired - Lifetime
- 1993-03-08 EP EP98202777A patent/EP0891982B1/en not_active Expired - Lifetime
- 1993-03-08 EP EP93906490A patent/EP0589004B2/en not_active Expired - Lifetime
-
1998
- 1998-02-28 KR KR1019980701532A patent/KR100259223B1/ko not_active IP Right Cessation
- 1998-07-09 US US09/112,206 patent/US6210903B1/en not_active Expired - Lifetime
-
1999
- 1999-06-23 GR GR990401678T patent/GR3030595T3/el unknown
-
2003
- 2003-04-11 JP JP2003107716A patent/JP2004002379A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0589004T3 (da) | Fremgangsmåde til bestemmelse af peptider, som hører til immunologisk vigtige epitoper af HCV | |
AU600466B2 (en) | Htlv-iii envelope peptides | |
EA200100943A1 (ru) | Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител | |
RU96102594A (ru) | Тандемные синтетические hiv-1 пептиды | |
NO863803L (no) | Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids). | |
DK268588D0 (da) | Syntetisk peptidantigen til detektering af hiv-2-infektion | |
DE69131149D1 (de) | Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe | |
DK0527760T3 (da) | Fremgangsmåder og præparater til vaccination mod HIV | |
UA39944C2 (uk) | Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі | |
NO881151L (no) | Syntetisk hiv-1-antigen. | |
DE69013950D1 (de) | Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen. | |
ATE87103T1 (de) | Immunochemisches reagenz. | |
EA200300335A1 (ru) | Регуляторные и вспомогательные пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич | |
JP2003525014A5 (ko) | ||
DE59309950D1 (de) | HCV Peptidantigene und Verfahren zur Bestimmung von HCV | |
SE9000595D0 (sv) | New peptides, diagnostic antigens and an immunoassay method | |
DE3579856D1 (de) | Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern. | |
GR3033885T3 (en) | Synthetic antigens for the detection of aids-related disease caused by LAV-2. | |
DE3679926D1 (de) | Nachweis von human-t-zellen-leukemievirus des typs-iii. | |
SE9101863D0 (sv) | Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar | |
RU2007108306A (ru) | Модифицированные пептиды вич-1 и их применение для обнаружения антител против вич | |
Sallberg et al. | The Antigen/Antibody Specificity Exchanger: A New Peptide-Based Tool for Re-directing Antibodies of Other Specificities to Recognize the V3 Domain of HIV-1 GP120 |